Interrelationship between RU38486 and the P450 activities in rat liver

Area of Science:

• Pharmacology
• Biochemistry
• Drug Metabolism

Background:

• Microsomal P450 monooxygenases are crucial for drug and steroid biotransformation.
• The antiglucocorticoid RU38486 is an 11 beta-substituted nor-steroid with potential interactions within the P450 system.

Purpose of the Study:

• To investigate the role of specific P450 forms in RU38486 metabolism.
• To determine if RU38486 influences the P450 spectrum and steroid-induced P450 activity.

Main Methods:

• Adult rats were pretreated with inducers of specific P450 forms.
• Liver microsomes were used to assess RU38486 metabolic activity.
• The effect of RU38486 on P450 spectrum and induction by other steroids was investigated.

Main Results:

• Phenobarbital and pregnenolone 16 alpha-carbonitrile increased RU38486 metabolism, while methylcholanthrene decreased it.
• P450 forms IIIA, IIB1,2, and IIC7 were identified as potential mediators of RU38486 degradation.
• RU38486 treatment decreased P450 activity and antagonized P450 induction by other steroids, including glucocorticoids.

Conclusions:

• RU38486 is metabolized by hepatic P450 enzymes, with specific forms implicated in its degradation.
• RU38486 exhibits inhibitory effects on P450 activity and antagonizes steroid-induced P450 induction.
• The findings suggest potential for drug interactions involving RU38486 due to its influence on the P450 system and endogenous hormonal status.